Are carotenoid supplements recommended for preventing or treating lung cancer, particularly in smokers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Carotenoid Supplements and Lung Cancer: Do Not Use

β-carotene supplementation is strongly contraindicated for lung cancer prevention in individuals with a smoking history of greater than 20 pack-years, as it increases lung cancer incidence, lung cancer mortality, and all-cause mortality (Grade 1A recommendation). 1

Critical Evidence from Clinical Trials

The evidence against carotenoid supplementation comes from two landmark randomized controlled trials:

The ATBC Trial

  • 29,133 male smokers followed for 5-8 years
  • β-carotene supplementation (20 mg/day) resulted in 18% higher lung cancer incidence (95% CI: 3-36%, P=0.02) 2
  • The harmful effect was strongest in heavy smokers (≥20 cigarettes/day: RR=1.25) and those with higher alcohol intake (≥11g ethanol/day: RR=1.35) 3
  • Total mortality increased 8% in the β-carotene group, primarily from lung cancer and ischemic heart disease 2

The CARET Trial

  • 18,314 smokers, former smokers, and asbestos-exposed workers
  • Combined β-carotene and vitamin A supplementation showed RR of 1.28 for lung cancer (95% CI: 1.04-1.57, P=0.02) 1
  • Among current smokers specifically: RR=1.40 (95% CI: 1.07-1.87) 1

Recent Confirmatory Evidence

A 2019 analysis demonstrated that the harmful effect of β-carotene persists regardless of cigarette tar or nicotine content, with increased risk across all cigarette types (HR=1.31 for ultralight to HR=1.22 for non-filtered) 4. This eliminates any notion that "safer" cigarettes might mitigate the risk.

The Dietary vs. Supplement Paradox

This is a critical distinction that patients must understand:

  • Dietary carotenoids from fruits and vegetables are protective: Multiple observational studies show that higher dietary intake of carotenoids from food sources is associated with reduced lung cancer risk 5, 6
  • Supplemental carotenoids are harmful in smokers: High-dose isolated β-carotene supplements increase lung cancer risk 1, 7

The CARET trial subanalysis revealed that participants consuming fruits and vegetables from dietary sources had reduced lung cancer risk in the placebo arm, with the strongest protection from rosaceae fruits and cruciferous vegetables 5. This protective effect disappeared—and reversed—with supplementation.

Who Should Absolutely Avoid Carotenoid Supplements

Contraindicated populations (Grade 1A):

  • Current smokers with >20 pack-year history
  • Former smokers with >20 pack-year history
  • Individuals with asbestos exposure and ≥15 pack-year smoking history
  • Anyone with a history of lung cancer (primary, secondary, or tertiary prevention) 1

Doses to avoid: 20-30 mg β-carotene daily or 50 mg every other day 1

Long-Term Supplement Use Carries Additional Risk

A 2009 cohort study found that long-term use (>4 years) of individual β-carotene, retinol, and lutein supplements was associated with significantly elevated lung cancer risk:

  • β-carotene for small cell lung cancer: HR=3.22 (95% CI: 1.29-8.07)
  • Individual supplemental lutein: HR=2.02 (95% CI: 1.28-3.17) 8

Importantly, this risk elevation occurred regardless of smoking status or gender, suggesting harm extends beyond just heavy smokers 8.

Other Supplements Also Not Recommended

The American College of Chest Physicians guidelines extend these recommendations to other supplements (all Grade 1A):

  • Vitamin E (α-tocopherol): No benefit demonstrated 1
  • Retinoids and vitamin A: Not recommended 1
  • N-acetylcysteine and isotretinoin: Not recommended 1
  • Selenium: Not recommended for tertiary prevention (Grade 1B) 1

What Should Be Recommended Instead

Dietary approach (the only evidence-based strategy):

  • Encourage consumption of fruits and vegetables rich in carotenoids from whole food sources
  • Emphasize cruciferous vegetables (broccoli, Brussels sprouts, cauliflower, kale) and rosaceae fruits (apples, pears, peaches, berries) 5
  • Target at least 3 servings per day of non-starchy vegetables and fruits 5

Primary prevention priority:

  • Smoking cessation remains the single most important intervention for lung cancer prevention 1
  • Low-dose CT screening for eligible high-risk individuals

Common Pitfalls to Avoid

  1. Do not conflate dietary intake with supplementation: Patients often assume that if dietary carotenoids are protective, supplements must be better—the opposite is true in smokers
  2. Do not recommend "low-dose" β-carotene as a compromise: The harm has been demonstrated at standard supplemental doses; there is no established safe dose for smokers
  3. Do not assume former smokers are safe: The contraindication applies to both current and former smokers with significant pack-year histories 1
  4. Do not recommend multivitamins containing β-carotene to heavy smokers: Check supplement labels and advise avoidance

Mechanism of Harm (Context for Patient Education)

While dietary carotenoids act as antioxidants in physiologic doses, high-dose supplementation in the pro-oxidant environment of cigarette smoke may paradoxically promote carcinogenesis through oxidative metabolites and disruption of retinoid signaling pathways 9, 10. This explains why the harm is specific to smokers and dose-dependent.

References

Research

β-Carotene Supplementation and Lung Cancer Incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: The Role of Tar and Nicotine.

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2019

Research

Drugs for preventing lung cancer in healthy people.

The Cochrane database of systematic reviews, 2012

Research

Carotenoids for lung cancer chemoprevention and chemotherapy: Promises and controversies.

Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.